What is polypharmacy? A systematic review of definitions

[1] Roughead EE(2011)Multimorbidity, care complexity and prescribing for the elderly Aging Health 7 695-705

[2] Vitry AI(2010)Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study J Epidemiol Community Health 64 1036-1042

[3] Caughey GE(2011)Aging with multimorbidity: a systematic review of the literature Ageing Res Rev 10 430-439

[4] Gilbert AL(2008)Prescribing for older people BMJ 336 606-609

[5] Caughey GE(2010)Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 19 977-982

[6] Ramsay EN(2010)Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts Diabetes Res Clin Pract 87 385-393

[7] Vitry AI(2014)Clinical consequences of polypharmacy in elderly Expert Opin Drug Saf 13 57-65

[8] Gilbert AL(2008)Polypharmacy: misleading, but manageable Clin Interv Aging 3 383-389

[9] Luszcz MA(2007)Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems Br J Clin Pharmacol 63 187-195

[10] Ryan P(2005)Reduction of high-risk Polypharmacy drug combinations in patients in a managed care setting Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 1636-1645

[1] Roughead EE(2011)Multimorbidity, care complexity and prescribing for the elderly Aging Health 7 695-705

[2] Vitry AI(2010)Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study J Epidemiol Community Health 64 1036-1042

[3] Caughey GE(2011)Aging with multimorbidity: a systematic review of the literature Ageing Res Rev 10 430-439

[4] Gilbert AL(2008)Prescribing for older people BMJ 336 606-609

[5] Caughey GE(2010)Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 19 977-982

[6] Ramsay EN(2010)Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts Diabetes Res Clin Pract 87 385-393

[7] Vitry AI(2014)Clinical consequences of polypharmacy in elderly Expert Opin Drug Saf 13 57-65

[8] Gilbert AL(2008)Polypharmacy: misleading, but manageable Clin Interv Aging 3 383-389

[9] Luszcz MA(2007)Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems Br J Clin Pharmacol 63 187-195

[10] Ryan P(2005)Reduction of high-risk Polypharmacy drug combinations in patients in a managed care setting Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 1636-1645